Wilmington, Delaware, Nov. 10, 2023 (GLOBE NEWSWIRE) -- According to the recent report released by Allied Market Research, the global transdermal drug delivery systems market size is predicted to grow to $87,322.40 million by 2030, having gained a value of $52,476.50 million in 2020, showcasing a considerable CAGR of 4.9% from 2021 to 2030. This market report provides a comprehensive analysis of leading investment pockets, top market segments, market dynamics, market size and forecasts, competitive analysis, and regional analysis. It is an essential resource for the stakeholders, and leading market players to strategically plan and enhance their competitive advantage.
Request Sample of the Report on Transdermal Drug Delivery Systems Market Forecast 2032 - https://www.alliedmarketresearch.com/request-sample/485
Report Coverage and Details:
| Report Coverage | Details |
| Forecast Period | 2021-2030 |
| Base Year | 2020 |
| Market Size in 2020 | $52,476.50 Million |
| Market Size in 2030 | $87,322.40 Million |
| CAGR | 4.9% |
| No. of Pages in Report | 175 |
| Segments Covered | Type, Application, and Region |
| Drivers | Growth in the global population |
| Rising demand for geriatric medicine | |
| An increase in the number of individuals suffering from chronic conditions including heart disease, arthritis, and diabetes | |
| Opportunities | Advancements in existing transdermal drug delivery systems (TDDS) |
Recent Development in Transdermal Drug Delivery Systems Market
- In September, 2022, Corium, Inc., a fully-integrated biopharmaceutical company, announced the launch of ADLARITY (donepezil transdermal system) in the U.S. for the treatment of patients with mild, moderate, or severe dementia of the Alzheimer's type.
- In November, 2023, DifGen Pharmaceuticals LLC announced the launch of its second complex Transdermal product, generic Buprenorphine Transdermal System (Gx to Butrans(R)) in the US market.
Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/485
The global transdermal drug delivery systems market is categorized into various segments based on type, application, and region. It is offered in both tabular and graphical form, permitting an individual or a commercial organization to benefit perception into the highly profitable and swiftly expanding segments.
By type, the passive segment accounted for the major market share in 2020, acquiring nearly three-fifths of the global transdermal drug delivery systems market revenue. On the other hand, the active segment would cite the fastest CAGR of 5.6% throughout the forecast period.
By application, the analgesics segment garnered the major market share in 2020, holding around one-third of the global transdermal drug delivery systems market revenue. The motion sickness segment, simultaneously, would display the fastest CAGR of 6.3% throughout the forecast period.
For Procurement Information - https://www.alliedmarketresearch.com/purchase-enquiry/485
By region, the market across North America dominates the largest share in 2020, contributing to more than two-fifths of the global transdermal drug delivery systems market. However, the market across the Asia-Pacific region would exhibit the fastest CAGR of 6.1% throughout the forecast period. The Europe and LAMEA provinces are also studied in the report.
The report also provides an in-depth analysis of the leading players in the global transdermal drug delivery systems market including Novartis AG, Hisamitsu Pharmaceutical Co. Inc., Viatris Inc., Boehringer Ingelheim GmbH, Altaris, GlaxoSmithKline Plc., Bayer AG, Purdue Pharma L.P., Johnson & Johnson, and Endo International Plc.
Comprehensive Healthcare Industry Research Studies: -
Endoscopy Fluid Management Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
Prosthetics Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
Neonatal Ventilator Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
